Commercialization Strategy
Panacor possesses the ability to identify and in-license promising drug candidates to supplement its self-innovated development portfolio. The Company intends to utilize strategic outsourcing to efficiently develop products through Phase I/II proof of concept clinical stage, and then seek commercialization opportunities with industry partners for later stage development and worldwide marketing and sales. The Company aims to market its products through partnership with multi-national companies or companies with leading market shares in domestic markets, in each case with expertise in each respective product category and geographic region. This will enable the Company to leverage its resources and to accelerate commercialization of its products.
 
 
 

Figure: Panacor¡¦s Competitive Value Chain Position

To date, the Company has successfully formed several collaboration and licensing agreements with world renowned pharmaceutical companies such as Keryx of the US, Japan Tobacco/Torii of Japan, etc. We anticipate further licenses and collaborations to be continuously established in the near future.